Ibuprofen Market size was valued at USD 6532 Mn in 2021 and poised to grow at significant CAGR 5.6% from 2022-2028. Rising adoption of an intravenous drug delivery mode for acute pain management owing to faster commencement of action as associated to the additional routes (oral and transdermal mode of administration) as well as targeted property of drug delivery. IV Ibuprofen progresses management in pain through less dependency on opioid painkilling medicine, which may lead to numerous complications of health including sedation, dizziness, and others. Caldolor (Cumberland Pharmaceuticals) is predominantly an injectable Ibuprofen drug accessible in the market; henceforth, it partakes enormous demand with slight competition. However, prolonged process for approval coupled with restricted approvals in certain countries are projected to restraint the market growth. Key players in global Ibuprofen market enhance their product portfolio and consumer base by adopting striking market strategy like collaborations, acquisitions, and technological innovations, among others. For instance, Feb 04, 2015- Harbin Gloria Pharma will pay a considerable amount to acquire a maximum stake in Shanxi Powerdone, which makes chemical drugs and compound preparations. This report gives a comprehensive outlook on Ibuprofen across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of application, formula type, and regions. This report studies global Ibuprofen market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global Ibuprofen market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Ibuprofen market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global Ibuprofen market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global Ibuprofen products.
Fastest Growing Market
Ibuprofen are predominantly used for various health complications such as pain, fever, inflammation, others. Treatment of inflammation with the aid of Ibuprofen is one of the major applications. Ibuprofen is generally used besides most often recommended NSAID.2,3 It is a non-selective inhibitor of cyclo-oxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2).4 Though its anti-inflammatory properties might be weaker as compared to the other NSAIDs, it devours a conspicuous analgesic and antipyretic role. Its effects are in arrears to the inhibitory actions on cyclo-oxygenases, which are involved in the synthesis of prostaglandins. Prostaglandins have a significant part in the production of fever, pain, inflammation.
The ibuprofen market is projected to expand at a CAGR of 5.6% during the forecast period
Cumberland Pharmaceuticals Inc, Alveda Pharmaceuticals, Inc. (Acquired by Teligent, Inc.), CSL Limited, Sandor Medicaids Pvt. Ltd., Soho Industri Pharmasi, Germin MED
North America is the fastest-growing region for ibuprofen market